Crossmark

Safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke patients with direct oral anticoagulation: experience from a German stroke center

Crossref DOI link: https://doi.org/10.1186/s42466-025-00450-8

Published Online: 2025-11-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mers, Lena

Bogdanova, Anna

Sekita, Alexander

Singer, Ludwig

Schmidt, Manuel

Kallmuenzer, Bernd

Schwab, Stefan

Gerner, Stefan T. https://orcid.org/0000-0001-6020-8290
Funding

Funding for this research was provided by:

Universitätsklinikum Erlangen
License Information

Text and Data Mining valid from 2025-11-14

Version of Record valid from 2025-11-14
More Information

Article History

Received: 19 May 2025

Accepted: 4 November 2025

First Online: 14 November 2025

Declarations

:

: This study was conducted following the approval of the ethics committee. The ethics vote number 377_17 Bc was obtained for the project titled “Clinical follow-up of patients with acute stroke” on 25 May 2020.

: All authors have reviewed and approved the final manuscript for publication.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below